Icon

MYCAPSSA (nda208232)- (EQ 20MG BASE)

OCTREOTIDE ACETATE CHIESI
EQ 20MG BASE
Yes Yes
2040-Dec-28 Expired
None 2023-Jun-26
None No
MYCAPSSA is a somatostatin analog indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 20MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.